Paid Clinical Trials in Carmel, IN
As of July 2026, 75 paid clinical trials are recruiting in Carmel, Indiana. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Carmel offers studies at sites including IU Health North Hospital for conditions such as Geographic Atrophy, Geographic Atrophy Secondary to Age-related Macular Degeneration, Age-Related Macular Degeneration, Anatomic Stage I Breast Cancer AJCC v8. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Trials by specialty in Carmel
Trials by drug in Carmel
Filter results
Newly added in Carmel
Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.
72 clinical trials
A Study to Evaluate Efficacy, Safety, and Immunogenicity With ABP 938 8 mg Versus EYLEA® HD (Aflibercept) in Participants With Neovascular Age-related Macular Degeneration
A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-002)
COMO: A Phase 3 Randomized, Double-Masked Study Comparing the Efficacy of EYP-1901 Against Aflibercept in DME
CAPRI: A Phase 3 Randomized, Double-Masked Study Comparing the Efficacy of EYP-1901 Against Aflibercept in DME
Efficacy and Safety Study of Ixoberogene Soroparvovec (Ixo-vec) in Participants With Neovascular Age-related Macular Degeneration (AQUARIUS)
A Phase 2, Randomized, Placebo Controlled, Multicenter, Masked Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacodynamics of Multidose APL 3007 in Combination With Syfovre/Pegcetacoplan (APL-2) in Patients Diagnosed With Geographic Atrophy Secondary to Age Related Macular Degeneratio
Study to Assess the Injection Burden, Adverse Events, Change in Disease Activity, and Long-Term Preservation of Visual Acuity of Surabgene Lomparvovec in Adult Participants With Neovascular Age-Related Macular Degeneration (nAMD)
A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)
Study to Evaluate Efficacy and Safety of ONL1204 in Patients With GA Associated With AMD
Registry of Patients With Brain Tumors Treated With STaRT (GammaTiles)
Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
A Phase 3 Study to Evaluate the Efficacy and Safety of Intravitreal KSI-101 in Participants With Macular Edema Secondary to Inflammation (MESI) - PINNACLE
A Phase 3 Study to Evaluate the Efficacy and Safety of Intravitreal KSI-101 in Participants With Macular Edema Secondary to Inflammation (MESI) - PEAK
ARTIST: Aortic Regurgitation Trial Investigating Surgery Versus Trilogy™
Copper Cu 64 PSMA I&T PET Imaging in Men With Newly Diagnosed Prostate Cancer
Single Intravitreal (IVT) Injection of 4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macular Degeneration
Efficacy of the COronary SInus Reducer in Patients With Refractory Angina II
Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC
Metastatic Castrate-Resistant Prostate Cancer Subjects Treated With PROVENGE® + One Infusion of Sipuleucel-T
Assessment of the Safety and Efficacy of 0.1% RGN-259 Ophthalmic Solution for the Treatment of NK: SEER-2
A Study to Develop a Blood-based Test for Aiding the Diagnosis/Prognosis of Traumatic Brain Injury in Adults and for Monitoring the Development of Secondary Events in Patients Diagnosed With Traumatic Brain Injury
A Study to Evaluate the Effectiveness of IDCT (Intradiscal Cell Therapy) in Subjects With One Level, Symptomatic Mild to Moderate Lumbar Degenerative Disc Disease
A Study to Test Whether BI 1815368 Helps People With an Eye Condition Called Diabetic Macular Edema
A Study to Evaluate TAR-210 Versus Intravesical Chemotherapy Treatment in Participants With High Risk Non-Muscle-Invasive Bladder Cancer
The Ailliance Post-Market Clinical Study
4D-150 in Patients With Neovascular (Wet) Age-Related Macular Degeneration
A Multicenter, Randomized, Vehicle-Controlled, Double-Masked to Open-Label Study to Evaluate the Safety and Efficacy of Lacripep in Subjects With Neurotrophic Keratitis
An Optimised GA Interventional Trial (Opti-GAIN) to Test if Treatment With CTx001 is Safe and Works for People With Geographic Atrophy (GA)
Study to Assess the Adverse Events and How Intravitreal ABBV-6628 Moves Through the Body of Adult Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration
A Non-Interventional Study Observing Short-Term Progression in Geographic Atrophy (GA)
Aptis PRUJ Prosthesis for the Treatment of Patients With Proximal Radial Ulna Joint Disorders.
NV PSR INSPIRE-A Pipeline™ Vantage Post Approval Study
Study to Evaluate the Safety and Efficacy of CSB-001 Ophthalmic Solution 0.1% in Subjects With Limbal Stem Cell Deficiency
PerQdisc Traditional Feasibility Trial.
Study to Evaluate the Safety and Efficacy of CSB-001 Ophthalmic Solution 0.1% in Subjects With Corneal Scars
A Study Comparing KB801 Verse Placebo in Patients With Stage 2 or 3 Neurotrophic Keratitis
Study to Evaluate the Safety of CG-P5 Peptide Eye Drops in Patients Diagnosed With Age-related Wet Macular Degeneration
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Top Research Study Locations in Carmel
Researchers run research studies in Carmel, IN at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| IU Health North Hospital | Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Endometrial Clear Cell Adenocarcinoma | 19 |
| Midwest Eye Institute | Geographic Atrophy Secondary to Age-related Macular Degeneration, Macular Edema Secondary to Inflammation, Geographic Atrophy | 6 |
| Associated Vitreoretinal and Uveitis Consultants | Age-Related Macular Degeneration, Choroidal Neovascularization, Geographic Atrophy | 4 |
| IU Health Joe and Shelly Schwarz Cancer Center | Estrogen-receptor-low Breast Cancer, HPV Positive Cancer, Metastatic Breast Cancer | 3 |
| Indiana Spine Group | Degenerative Disc Disease, Discogenic Low Back Pain, Spinal Deformity | 3 |
| Adverum Clinical | Neovascular Age-Related Macular Degeneration (nAMD), Wet AMD | 3 |
| Ascension St. Vincent Cardiovascular Research Institute | Coronary Artery Disease | 2 |
| Ascension St. Vincent Heart Center | Aortic Insufficiency, Aortic Regurgitation, Aortic Valve Insufficiency | 2 |
| Associated Vitreoretinal and Uveitis Consultants LLC | Macular Edema Secondary to Inflammation | 2 |
| Goodman Campbell Brain and Spine | Brain Tumor, Brain Tumor - Metastatic, Brain Tumor, Adult Meningioma | 2 |
| Midwest Cornea Associates | Neurotrophic Keratitis | 2 |
| Midwest Cornea Associates, LLC | Corneal Scar, Limbal Stem Cell Deficiency | 2 |
| Urology of Indiana | Metastatic Castration-Resistant Prostate Cancer (mCRPC), Non-Muscle Invasive Bladder Neoplasms | 2 |
| Retina Partners Midwest, P.C. | Age - Related Macular Degeneration (AMD), Geographic Atrophy (GA), Age-Related Macular Degeneration | 2 |
| Urology of Indiana - Carmel | High-Risk Non-Muscle-Invasive Bladder Cancer, Metastatic Castration-resistant Prostate Cancer (mCRPC), Prostatic Neoplasms | 2 |
| Ascension St. Vincent Hospital Indianapolis Goodman Campbell Brain and Spine | Intracranial Aneurysm | 1 |
| Ascension St. Vincent's Hospital | Cardiovascular Diseases, Heart Diseases, Heart Valve Diseases | 1 |
| Associated Vitreoretinal & Uveitis Consultants - Carmel | DME, Diabetic Macular Edema, Diabetic Macular Edema (DME) | 1 |
| CBCC Global Research Site:004 | Age-related Wet Macular Degeneration | 1 |
| Claris Investigative Site | Limbal Stem Cell Deficiency | 1 |
| Clinical Trial Site | High Cardiovascular Risk, High Risk Cardiovascular Disease, Hypertension | 1 |
| Glaukos Investigative Site | Persistent Corneal Epithelial Defect | 1 |
| Goodman Campbell Brain and Spine/Ascension | Traumatic Brain Injury | 1 |
| IU Health Beltway Surgery Center | Lumbar Spinal Stenosis | 1 |
| IU Health North / Schwarz Cancer Center | Metastatic Cancer | 1 |
Active & Upcoming Studies in Carmel (2026)
Recruiting trials in Carmel grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (28 active studies)
- Safety and Efficacy of OTL78 (Zopocianine) · Phase 2, Phase 3 · Clinton Bahler
- Induction Pembrolizumab and Chemotherapy Followed by Pembrolizumab Before Chemoradiation and Pembrolizumab Maintenance Compared to Standard Chemoradiation With Pembrolizumab Followed by Pembrolizumab Maintenance in High-Risk Cervical Cancer · Phase 3 · National Cancer Institute (NCI)
Eye & vision (18 active studies)
- A Study to Evaluate Efficacy, Safety, and Immunogenicity With ABP 938 8 mg Versus EYLEA® HD (Aflibercept) in Participants With Neovascular Age-related Macular Degeneration · Phase 3 · Amgen
- A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-002) · Phase 2, Phase 3 · EyeBiotech Ltd.
Cardiovascular (4 active studies)
- TRIFORMIS RESILIA Real-world Study Assessing Safety and Performance (TRIBLAZE Study) · Edwards Lifesciences
- Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease · Phase 3 · Alnylam Pharmaceuticals
Neurology & pain (3 active studies)
- Rapid Evacuation and Access of Cerebral Hemorrhage Trial · Emory University
- PerQdisc Traditional Feasibility Trial. · Spinal Stabilization Technologies
Common conditions studied in Carmel
- Geographic Atrophy (3 active studies)
- Geographic Atrophy Secondary to Age-related Macular Degeneration (3 active studies)
- Age-Related Macular Degeneration (2 active studies)
- Anatomic Stage I Breast Cancer AJCC v8 (2 active studies)
- Anatomic Stage II Breast Cancer AJCC v8 (2 active studies)
- Coronary Artery Disease (2 active studies)
Leading research sponsors in Carmel
- Indiana University
- NRG Oncology
- National Cancer Institute (NCI)
- Alliance for Clinical Trials in Oncology
- Claris Biotherapeutics, Inc.
Frequently asked questions
How many paid clinical trials are currently recruiting in Carmel?
There are approximately 75 recruiting clinical trials in Carmel, Indiana listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Carmel pay participants?
Most recruiting trials in Carmel compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Carmel?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Carmel?
The most common conditions under active study in Carmel include Geographic Atrophy (3), Geographic Atrophy Secondary to Age-related Macular Degeneration (3), Age-Related Macular Degeneration (2), Anatomic Stage I Breast Cancer AJCC v8 (2), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Carmel?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Carmel on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Carmel?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Carmel?
Recruiting research sites in Carmel include IU Health North Hospital, Midwest Eye Institute, Associated Vitreoretinal and Uveitis Consultants, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Carmel right now?
The largest active categories in Carmel are Cancer & tumors (28), Eye & vision (18), Cardiovascular (4). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.